Searched for
INDIA DRUG NORMS
India's stance on killing of 3 seafarers is strongest that can be, says Foreign Affairs Expert Robinder SachdevForeign affairs expert Robinder Sachdev believes the killing of three Indian seafarers by US forces constitutes a war crime. He suggests fa...- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Market Trading Guide: Akums Drugs among 4 stock recommendations for ThursdayDomestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain ...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- Tripura arrests 3,705 illegal migrants since 2022; 3,463 are BangladeshisA senior Home Department official stated that 965 Bangladeshi nationals were arrested in 2022, followed by 1,014 in 2023; 947 in 2024; and ...
- Govt flags ‘high-risk’ crypto system in note to Parliamentary panelIndia's virtual digital asset sector is now high risk. Intelligence reports reveal extensive illegal activities including drug trafficking ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Rs 70,00,000 worth fake Mounjaro injections seized in Gurgaon; Police expose illegal weight-loss drug racket in NCRGurgaon Drug Racket: Authorities in Gurgaon have busted a major illegal pharmaceutical racket involving spurious Mounjaro KwikPen (tirzepat...
- Cancer burden rising, all hands on the deckIndia faces a critical shortage of cancer specialists. A new rule for the PMJAY scheme now bars experienced oncologists without specific de...
- Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Syngene MDThe recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...
- India tightens grip on GLP-1 supply chain amid misuse concerns, expands crackdown on unapproved drugsIndia's drug regulator is increasing checks on weight loss drug sales. This action follows inspections of pharmacies and clinics nationwide...
- Pharma companies must file compliance strategyDrugmakers must complete a gap analysis and submit their compliance strategy to extend Schedule M implementation. Small and medium manufact...
- Government eases norms to test, launch drugsEthics Committee has also been allowed to add trial sites and investigators without the need to obtain a no objection certificate from the ...
- Uncertainty in regulatory regime forcing Indian firms like Biocon shift drug trials abroadBlame administrative lethargy, not judicial overreach, for regulatory vacuum, making India forgo a valuable economic activity, which raises...
- Regulator mulls changes in labelling norms for drugsOfficials at the DCGI said the changes in the norms will ensure that consumers do not mistake the marketing firm to be the manufacturer of ...
- USFDA pulls up Smruthi Organics for norms violation in unitSmruthi Organics today said it has received a notification from the USFDA highlighting violations of manufacturing norms at its Solapur pla...
- Lobby fears norms violation in Cipla's biosimilar drugA lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept.
- GMP norms for drug cos put off by 1 yearThe government has deferred compulsory implementation of the new good manufacturing practices (GMP) norms for the drug industry by one year.
Load More
